PONATinib 30 MG Oral Tablet

RxCUI: 1726637
RxNorm name: PONATinib 30 MG Oral Tablet
Display name: PONATinib 30 MG Oral Tablet
Full name: PONATinib 30 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Iclusig	PONATINIB HYDROCHLORIDE	Takeda Pharmaceuticals America, Inc.	16d804b6-4957-43ee-b18c-3b36ec37c5ac	2026-04-29	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1726637

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
16d804b6-4957-43ee-b18c-3b36ec37c5ac	PONATinib 30 MG Oral Tablet	PSN	19	These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG ® (ponatinib) tablets, for oral use Initial U.S. Approval: 2012	20260429
16d804b6-4957-43ee-b18c-3b36ec37c5ac	ponatinib 30 MG Oral Tablet	SCD	19	These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG ® (ponatinib) tablets, for oral use Initial U.S. Approval: 2012	20260429
16d804b6-4957-43ee-b18c-3b36ec37c5ac	ponatinib (as ponatinib hydrochloride) 30 MG Oral Tablet	SY	19	These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG ® (ponatinib) tablets, for oral use Initial U.S. Approval: 2012	20260429